SBTX - Silverback Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-06-26)
Last
 18.08		 Change
 ⇑ +0.82   (+4.75%)		 Volume
  1,802,898
Open
 17.30		 High
 18.21		 Low
 17.27
8EMA (Daily)
 16.55		 40EMA (Daily)
 14.84		 50EMA (Daily)
 14.60		 STO (Daily)
 91.680		 MACD Hist (Daily)
 0.613
8EMA (Weekly)
 15.446		 40EMA (Weekly)
 13.26		 50EMA (Weekly)
 12.83		 STO (Weekly)
 90.373		 MACD Hist (Weekly)
 0.737
Company Profile
Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com